摘要
血栓调节蛋白 (TM)是反映血管内皮损伤的一个分子标记物。糖尿病伴微血管病变时血TM水平显著增高 ,其中以糖尿病肾病时TM变化最为明显。血TM增高与血管内皮损伤程度、肾功能损害等有关。测定TM水平对糖尿病微血管病变 。
出处
《国外医学(内分泌学分册)》
2000年第3期123-125,共3页
Foreign Medical Sciences(Section of Endocrinology)
参考文献17
-
1Sadler IE. Thrombomodulin structure and function 〔J〕.Thromb Hacmost,1997,78:392~395.
-
2Aso Y,Inukai T,Takemura Y,et al.Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients:possible application as a marker for vascular endothelial injury 〔J〕.Metabolism,1998,47:362~365.
-
3Boffa MC,Karmochkine M.Thrombomodulin:an overview and potential implications in vascular disorders 〔J〕.Lupus,1998,7(Suppl 2):S120~S125.
-
4Sumida Y,Wada H,Fujii M,et al.Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus 〔J〕.Blood Coag Fibr,1997,8:303~307.
-
5Mormile A,Veglio M,Gruden G,et al.Physiological inhibitors of blood coagulation and prothrombin fragment F1+2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy 〔J〕.Acta Diabetol,1996,33:241~245.
-
6Rinno H,Kuramoto T,Iijima T,et al.Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy 〔J〕.J Clin Lab Anal,1996,10:119~124.
-
7Reverter JL,Reverter JC,Tassies D,et al.Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy:a prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus 〔J〕.Am J Hematol,1997,56:93~99.
-
8Hofmann MA,Kohl B,Zumbach MS,et al.Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM 〔J〕.Diabetes Care,1998,21:841~848.
-
9Hofmann MA,Schiekofer S,Isermann B,et al.Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappa B 〔J〕.Diabetologia,1999,42:222~232.
-
10Magriples U,Hsu CD,Chan DW,et al.Circulation thrombomodulin levels and clinical correlation in pregnant diabetes 〔J〕.Am J Perinatol,1997,14:605~607.
同被引文献28
-
1谢璇,丁石梅,徐静,王玉环,戴信刚,王俊宏,吴娟娟.2型糖尿病肾病患者血栓调节蛋白的变化[J].西安交通大学学报(医学版),2004,25(4):379-381. 被引量:2
-
2曾正陪,唐丹,孙梅励,关炳江,吕朝,王.血浆内皮素与糖尿病血管病变的关系[J].中华内科杂志,1994,33(7):467-469. 被引量:78
-
3Galajda P, Martinka E, Mokan M, et al. Endothelial markers in diabetes meUitus[J]. Thromb Res, 1997, 85( 1 ) : 63 - 65.
-
4Aso Y, Inukai T, Takemura Y, et al. Mechanisms of devation of serum and urinary Concentrations of soluble thrombomodulin in diabetic patient possible aplication as a marker for vascular endothelial injurry[J]. Metabolism, 1998, 47 : 262 - 265.
-
5Aso Y, Fujiwara Y, Tayama K, et al. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes[J]. Clin Chim Acta, 2000, 301 : 135 - 145.
-
6Tanaka A. Thrombomodulin in blood[J ]. Nippon Rinsho, 2002, 60 (suppl 8) : 469 - 474.
-
7Gabat S, Keller C, Kempe HP, et al. Plasma thrombomodulin : a marker for microveseular complications in diabetes mellitus[ J ]. Vesa, 1996, 25(3) :233 - 241.
-
8内科学.叶任高主编(第5版)[M].北京:人民卫生出版社,2000.569-570.
-
9Sumida Y, Wadar L, Fujii M, et al. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin dependent diahetes mellitus.Blood Coagul Fibrinolgsis, 1997,8:303-307.
-
10Aso Y, Inukai T, Takemura Y. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients possible applications as amarker for vascular endothelial injury.Metabolism, 1998,47:362-365.
引证文献4
-
1谢璇,丁石梅,徐静,王玉环,戴信刚,王俊宏,吴娟娟.2型糖尿病肾病患者血栓调节蛋白的变化[J].西安交通大学学报(医学版),2004,25(4):379-381. 被引量:2
-
2张爱华,付梅林,黄丽红,徐丽华,曹卫华,周力.2型糖尿病尿白蛋白排泄率与血栓调节蛋白的相关性研究[J].中华糖尿病杂志(1006-6187),2005,13(2):108-110. 被引量:3
-
3薛晔霞.糖尿病视网膜病变患者血浆血栓调节蛋白水平研究[J].内蒙古医学杂志,2009,41(3):276-279. 被引量:2
-
4徐进,江蓓,朱蕾,王言森,王少媛.糖尿病肾病患者血栓调节蛋白水平变化[J].中国慢性病预防与控制,2001,9(6):253-255. 被引量:4
二级引证文献11
-
1谢璇,丁石梅,徐静,王玉环,戴信刚,王俊宏,吴娟娟.2型糖尿病肾病患者血栓调节蛋白的变化[J].西安交通大学学报(医学版),2004,25(4):379-381. 被引量:2
-
2张爱华,付梅林,黄丽红,徐丽华,曹卫华,周力.2型糖尿病尿白蛋白排泄率与血栓调节蛋白的相关性研究[J].中华糖尿病杂志(1006-6187),2005,13(2):108-110. 被引量:3
-
3周力,曹卫华,张爱华,徐丽华,黄丽红.2型糖尿病患者尿白蛋白排泄率与血栓调节蛋白的相关性[J].中国临床康复,2005,9(31):86-87.
-
4白晓丽,刘素筠.血栓调节蛋白和纤溶酶原激活物抑制物-1在糖尿病肾病中的作用[J].医学综述,2006,12(6):374-376. 被引量:1
-
5吴红光,韩景银,张忠广.联合检测血浆同型半胱氨酸和血栓调节蛋白在糖尿病微血管病变中的应用[J].中国糖尿病杂志,2007,15(4):231-232. 被引量:3
-
6薛晔霞.糖尿病视网膜病变患者血浆血栓调节蛋白水平研究[J].内蒙古医学杂志,2009,41(3):276-279. 被引量:2
-
7徐丽,王芳.2型糖尿病患者血清同型半胱氨酸与颈动脉内膜中层厚度、血管内皮细胞损伤的相关性[J].江苏医药,2010,36(7):757-759. 被引量:6
-
8郑金艳,张爱华,李佩贤,李锋,马世瞻,孙文秀.T2DM患者UAE与vWF:Ag及血小板参数的相关性研究[J].潍坊医学院学报,2011,33(3):185-188.
-
9吕茜.糖尿病视网膜病变相关危险因素研究进展[J].山西医药杂志(上半月),2012,41(9):887-889. 被引量:3
-
10卢庆乐,田玫玲,吴殿水.2型糖尿病视网膜病变患者血栓前状态标志物检测结果分析[J].检验医学与临床,2013,10(20):2653-2654.
-
1韩萍,郭阳,郑玉祥,刘英敏,郭津津,王富伟.血浆脂蛋白(a)、载脂蛋白A_1、B与老年人NIDDM大血管病变的关系[J].中华老年医学杂志,1994,13(5):290-292. 被引量:12
-
2孙卫华,张晓梅,李晓丽,时照明,裴晓艳,吴道爱.同型半胱氨酸和C反应蛋白与2型糖尿病大血管病变的关系研究[J].蚌埠医学院学报,2014,39(7):852-854. 被引量:3
-
3刘润华,刘聪,刘英敏,高云霞,张正侯,张雨晨.糖尿病患者血清肿瘤坏死因子 α 的水平及临床意义[J].中国实用内科杂志,1997,17(5):288-289. 被引量:14
-
4周政.2型糖尿病患者大血管病变与C反应蛋白的关系及辛伐他汀疗效分析[J].蚌埠医学院学报,2006,31(6):618-620.
-
5裴海成,林星子,桂成淑,李钟范,张长义,金成吉,朴莲善,李辉星,金基焕.内皮素及降钙素基因相关肽与糖尿病血管并发症[J].延边大学医学学报,1998,21(1):14-18.
-
6关晓宏,刘德辉,朱西娥,刘慧英.皮温生物反馈对Ⅱ型糖尿病人周围血管功能的影响[J].空军总医院学报,1999,15(1):42-43.
-
7刘晓玲,田巧兰.糖尿病性血管病变及有关并发症与糖尿病指数的建立[J].山西医科大学学报,1994,24(S1):27-29.
-
8张代民,李萍,许会彬,王援朝,张莹.老年2型糖尿病患者血小板参数和血清脂质的变化[J].临床军医杂志,2003,31(1):16-19. 被引量:1
-
9余斌杰,梁亦铨,单济川.糖尿病综合研究15年(1979-1994年)[J].中山医科大学学报,1995,16(1):1-8. 被引量:9
-
10关小宏,刘德辉,朱西娥,刘慧英.皮温生物反馈对糖尿病人周围血管的影响[J].空军总医院学报,2001,17(3):179-180. 被引量:2